Table 1.
(A) Patient backgrounds, (B) Patient data at the dialysis initiation.
| Total (n = 151) | Death ≤ 2 Y (n = 26) | Alive (n = 125) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (A) | |||||||||||
| Age (year; mean ± SD) | 65.7 ± 14.7 | 75.2 ± 13.4 | 63.8 ± 14.3 | ||||||||
| ≥ 80 (% [n]) | 16.6 (25) | 46.2 (12) | 10.4 (13) | ||||||||
| Gender ; male (% [n]) | 70.2 (106) | 65.4 (17) | 71.2 (89) | ||||||||
| Primary cause of ESRD | |||||||||||
| DM (% [n]) | 29.8 (45) | 30.8 (8) | 29.6 (37) | ||||||||
| CGN (% [n]) | 25.2 (38) | 19.2 (5) | 26.4 (33) | ||||||||
| Nephrosclerosis (% [n]) | 23.2 (35) | 7.7 (2) | 26.4 (33) | ||||||||
| Others (% [n]) | 21.8 (33) | 42.3 (11) | 17.6 (22) | ||||||||
| Past history and complications | |||||||||||
| DM (% [n]) | 37.7 (57) | 34.6 (9) | 38.4 (48) | ||||||||
| Hypertension (% [n]) | 88.1 (133) | 69.2 (18) | 92.0 (115) | ||||||||
| Heart disease (% [n]) | 41.7 (63) | 61.5 (16) | 37.6 (47) | ||||||||
| Stroke (% [n]) | 13.9 (21) | 30.8 (8) | 10.4 (13) | ||||||||
| CVD (% [n]) | 47.7 (72) | 76.9 (20) | 41.6 (52) | ||||||||
| Cancer (% [n]) | 17.9 (27) | 30.8 (8) | 15.2 (19) | ||||||||
| AKI (% [n]) | 13.2 (20) | 61.5 (10) | 8.0 (10) | ||||||||
| Nephrologist’s care < 6 months (% [n]) | 21.1 (32) | 53.8 (14) | 14.4 (18) | ||||||||
| CKD stage at first visit | |||||||||||
| 1 (% [n]) | 3.3 (5) | 0 (0) | 4.0 (5) | ||||||||
| 2 (% [n]) | 9.9 (15) | 7.7 (2) | 10.4 (13) | ||||||||
| 3 (% [n]) | 17.2 (26) | 11.4 (3) | 16.8 (21) | ||||||||
| 4 (% [n]) | 31.1 (47) | 34.6 (9) | 30.4 (38) | ||||||||
| 5 (% [n]) | 39.7 (60) | 46.2 (12) | 38.4 (48) | ||||||||
| Emergent initiation (% [n]) | 47.0 (71) | 92.3 (24) | 37.6 (47) | ||||||||
| Peritoneal dialysis (% [n]) | 10.6 (16) | 3.8 (1) | 12.0 (15) | ||||||||
| (B) | |||||||||||
| Body surface area (m2; mean ± SD) | 1.65 ± 0.20 | 1.57 ± 0.16 | 1.66 ± 0.20 | ||||||||
| Systolic blood pressure (mmHg; mean ± SD) | 151.8 ± 24.4 | 139.3 ± 28.3 | 154.3 ± 22.8 | ||||||||
| CTR in chest X-ray (%; mean ± SD) | 52.6 ± 6.7 | 58.0 ± 7.9 | 51.5 ± 5.8 | ||||||||
| EF in ultrasonic cardiography (%; mean ± SD) | 64.2 ± 12.2 | 58.4 ± 18.1 | 65.2 ± 10.7 | ||||||||
| eGFR (ml/min/1.73 m2; mean ± SD) | 6.16 ± 3.89 | 9.80 ± 1.40 | 5.40 ± 2.16 | ||||||||
| Hb (g/dl; mean ± SD) | 9.21 ± 1.31 | 9.16 ± 1.67 | 9.22 ± 1.23 | ||||||||
| Alb (g/dl; mean ± SD) | 3.13 ± 0.60 | 2.69 ± 0.73 | 3.22 ± 0.52 | ||||||||
| CRP (mg/dl; mean ± SD) | 1.46 ± 3.08 | 4.93 ± 5.60 | 0.74 ± 1.44 | ||||||||
| Medical costs (× 104 JPY; mean ± SD) | 257 ± 316 | 611 ± 564 | 183 ± 159 | ||||||||
| Period of hospitalization (days; mean ± SD) | 42.9 ± 45.3 | 79.7 ± 87.2 | 35.2 ± 26.1 | ||||||||
| Medical costs per day (× 104 JPY/day; mean ± SD) | 6.08 ± 3.86 | 10.0 ± 7.97 | 5.27 ± 1.15 | ||||||||
Data are presented as mean ± standard deviation (range) unless otherwise stated.
ESRD end-stage renal disease, DM diabetes mellitus, CGN chronic glomerular nephropathy, CVD cardiovascular disease, AKI acute kidney injury, CKD chronic kidney disease, CTR cardio thoracic ratio, EF ejection fraction, JPY Japanese Yen.